Biocompatible medical article and method

• US 5,607,475 A
• Filed: 08/22/1995
• Issued: 03/04/1997
• Est. Priority Date: 08/22/1995
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Hendriks, Marc, Verhoeven, Michel, Cahalan, Patrick T., Fouache, Benedicte, Cahalan, Linda L.
• Primary Examiner(s): Weiss, John G.
• Assistant Examiner(s): CUDDIHY, FRANCIS KEVIN
• Application Number:
  US08/518,129
• Time in Patent Office: 560 Days
• Field of Search: 623/1, 623/7, 623/12, 623/11, 606/194, 606/195, 427/2.1, 427/2.24, 427/2.25, 424/422, 424/423, 424/424, 525/54.1
• US Class Current: 424/423
• CPC Class Codes: A61L 27/28 Materials for coating prostheses
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 33/0029 using an intermediate layer of polymer
• CPC Class Codes: A61L 33/0047 Enzymes, e.g. urokinase, streptokinase
• CPC Class Codes: C08L 33/02 Homopolymers or copolymers of acids; Metal or ammonium salts thereof
• CPC Class Codes: C08L 33/26 Homopolymers or copolymers of acrylamide or methacrylamide
• CPC Class Codes: Y10S 623/924 Material characteristic

Abstract

A medical article having a metal or glass surface with the surface having an adherent coating of improved biocompatibility. The coating is made by first applying to the surface an silane compound having a pendant vinyl functionality such that the silane adheres to the surface and then, in a separate step, forming a graft polymer on the surface with applied vinylsilane such that the pendant vinyl functionality of the vinylsilane is incorporated into the graft polymer by covalent bonding with the polymer. Biomolecules may then be covalently attached to the base layer.

Claims

1. An endoprosthesis having a metal surface contacting body fluids, the metal surface having a coating thereon comprising:

(a) a silane which includes a vinyl functionality, the silane adherent to the metal surface such that the vinyl functionality is pendant from the surface;

(b) a graft polymer, the graft polymer covalently bonded with the pendant vinyl functionality of the adherent silane, the graft polymer simultaneously formed and bonded to the pendant vinyl functionality by free radical reaction initiated by an oxidizing metal with at least one ethylenically unsaturated monomer selected from the group consisting of acrylamide and acrylic acid;

(c) a polyamine spacer covalently attached to the graft polymer; and

(d) a biomolecule covalently attached to the spacer.

2. The endoprosthesis of claim 1, wherein the silane includes a functional group selected from the group consisting of halogen, methoxy and ethoxy groups.

3. An endoprosthesis as in claim 2, in which the silane is trichlorovinylsilane.

4. An endoprosthesis as in claim 1, in which the polyamine spacer is a polyalkyleneimine.

5. An endoprosthesis as in claim 1, in which the biomolecule is an antithrombotic.

6. An endoprosthesis as in claim 5, in which the antithrombotic is selected from the group consisting of heparin and heparin derivatives.

7. An endoprosthesis having a metal surface contacting body fluids, the metal surface having a coating thereon comprising:

(a) a silane having the structure

space="preserve" listing-type="equation">C.sub.2 H.sub.3 --R--Si--X.sub.3,

wherein X is a halogen, methoxy or ethoxy group and R is an optional short chain alkyl group, the silane adherent to the metal surface such that the vinyl functional group is pendant from the surface;

(b) a graft polymer, the graft polymer covalently bonded with the pendant vinyl functionality of the adherent silane, the graft polymer simultaneously formed and bonded to the pendant vinyl functionality by free radical reaction initiated by an oxidizing metal with at least one ethylenically unsaturated monomer selected from the group consisting of acrylamide and acrylic acid; and

(c) a biomolecule covalently attached to the graft polymer.

8. The endoprosthesis of claim 7, wherein the biomolecule is covalently attached by means of an amine spacer.

9. The endoprosthesis of claim 8, wherein the amine spacer is a crosslinked polyalkyeneimine.

10. The endoprosthesis as in claim 7, in which the silane is trichlorovinylsilane.

11. The endoprosthesis of claim 7, wherein the biomolecule comprises an antithrombotic agent.

12. The endoprosthesis of claim 11, wherein the antithrombotic is selected from the group consisting of heparin and heparin derivatives.